Medcave Journal of Surgery Open Access

  surgery@medcavepublications.org

Current Issues.

Research Article

Treatment and Prognostic Factors of Subaracnoid Aneurysmatic Hemorrhage

José Manuel Ortega Zufiría

Aneurysmal Subarachnoid Haemorrhage (SAH) is a very serious neurosurgical problem, associated with high rates of morbidity and mortality. After the initial haemorrhage, up to 50% of the patients die, and 30-40% of the patients suffer a new bleeding during the first month. The percentage of deaths due to a new bleeding is between 60% and 75%. Both endovascular embolization and surgery treatments reduce the mortality rate and improve the quality of life of the survivors. In recent years, endovascular embolization has become the method of choice to prevent new bleeding, especially in Europe, widely replacing surgery. The aim of this study was to describe a series of patients with spontaneous subarachnoid haemorrhage, secondary to aneurysmal rupture, treated at the University Hospital of Getafe between 2010 and 2019, to study the different diagnostic and treatment options, and to define the most important prognostic factors. In addition, compare the results of both treatments (surgical and endovascular). Material and Methods: We studied 110 patients, 58 men and 52 women, with an average age of 40.8 years. A retrospective study has been carried out, reviewing clinical histories and collecting epidemiology. Results: Of the total, 25 patients have been treated surgically and 85 by endovascular embolization. It has been established that the best management in this type of patients is the performance of Computed Tomography (CT) of the skull and cerebral arteriography, as well as admission for surveillance in the ICU. Discussion: In this study, the neurological clinical situation at admission, the volume and distribution of blood in the CT and the age of the patient, seem to be the most influential variables in the final result.

GET IN TOUCH